|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cerevast Therapeutics, Inc.
| | | Phone: | (425) 821-1939 | Fax: | (425) 821-9313 | Year Established: | 2009 | Main Contact: | Bradford A. Zakes, President & CEO | | Other Contacts: | Andrew Leo, VP, Quality Anthony J. Alleman, COO Patrick Bobbitt, VP, Clinical Affairs Anthony J. Alleman, VP, Operations Gordon Brandt, M.D., CMO Kendall Stever, CFO Andrew Leo, VP, Quality Mike Rothmeyer, Senior VP, Global Sales and Marketing Gordon Brandt, M.D, CMO Andrew Leo, VP, Quality Mark Moehring, Ph.D., CTO W.J. Tyler, Ph.D., CSO Anthony J. Alleman, COO
| | Company Description | Cerevast Therapeutics is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast’s proprietary ultrasonic headframe called the ClotBustTM-ER, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy. | |
|
|
|
|
|